Arts-Way (ARTW) Director Granted 1,000 Fully Vested Restricted Shares
Rhea-AI Filing Summary
Randall C. Ramsey, a director of Arts-Way Manufacturing Co., received 1,000 fully vested restricted shares on 08/31/2025 under the company's director compensation plan. The transaction was reported on a Form 4 filed pursuant to Section 16. Following the grant, Mr. Ramsey beneficially owns 72,709 shares of the issuer's common stock, held in a direct capacity.
The reported shares were granted at a $0 purchase price and are described as fully vested restricted stock. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Ramsey and contains an explanation that the award represents director compensation.
Positive
- Director compensation granted: 1,000 fully-vested restricted shares were issued, aligning board interests with shareholders
- Clear disclosure: Form 4 reports direct beneficial ownership of 72,709 shares following the transaction
Negative
- None.
Insights
Director received a routine, fully vested restricted stock award; this appears consistent with standard board compensation.
The Form 4 discloses a non-derivative acquisition of 1,000 shares by a director under the director compensation plan, with no cash outlay reported. As a governance matter, issuance of restricted stock to directors is a common method to align interests with shareholders. The filing shows direct beneficial ownership of 72,709 shares post-transaction, which may modestly increase the director's alignment with long-term shareholders but does not suggest a material change to control or ownership concentration.
Transaction is procedural and small relative to typical market-cap impacts; not materially affecting ownership structure.
The Form 4 reports a grant of 1,000 fully vested restricted shares at $0, executed 08/31/2025. There are no derivative transactions, no exercise prices, and the filing indicates direct ownership. From a market perspective, this type of director compensation is informational for disclosure purposes but is unlikely to be material to investors or valuation given the absolute size of the grant versus total outstanding shares (not provided in the filing).